Engel, Sinah; Graetz, Christiane; Salmen, Anke; Muthuraman, Muthuraman; Toenges, Gerrit; Ambrosius, Björn; Bayas, Antonios; Berthele, Achim; Heesen, Christoph; Klotz, Luisa; Kümpfel, Tania; Linker, Ralf A; Meuth, Sven G; Paul, Friedemann; Stangel, Martin; Tackenberg, Björn; Then Bergh, Florian; Tumani, Hayrettin; Weber, Frank; Wildemann, Brigitte; ... (2020). Is APOE ε4 associated with cognitive performance in early MS? Neurology: Neuroimmunology and Neuroinflammation, 7(4) Wolters Kluwer Health 10.1212/NXI.0000000000000728
|
Text
Engel, 2020, APOE «4.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (273kB) | Preview |
OBJECTIVE
To assess the impact of APOE polymorphisms on cognitive performance in patients newly diagnosed with clinically isolated syndrome (CIS) or relapsing-remitting MS (RRMS).
METHODS
This multicenter cohort study included 552 untreated patients recently diagnosed with CIS or RRMS according to the 2005 revised McDonald criteria. The single nucleotide polymorphisms rs429358 (ε4) and rs7412 (ε2) of the APOE haplotype were assessed by allelic discrimination assays. Cognitive performance was evaluated using the 3-second paced auditory serial addition test and the Multiple Sclerosis Inventory Cognition (MUSIC). Sum scores were calculated to approximate the overall cognitive performance and memory-centered cognitive functions. The impact of the APOE carrier status on cognitive performance was assessed using multiple linear regression models, also including demographic, clinical, MRI, and lifestyle factors.
RESULTS
APOE ε4 homozygosity was associated with lower overall cognitive performance, whereas no relevant association was observed for APOE ε4 heterozygosity or APOE ε2 carrier status. Furthermore, higher disability levels, MRI lesion load, and depressive symptoms were associated with lower cognitive performance. Patients consuming alcohol had higher test scores than patients not consuming alcohol. Female sex, lower disability, and alcohol consumption were associated with better performance in the memory-centered subtests of MUSIC, whereas no relevant association was observed for APOE carrier status.
CONCLUSION
Along with parameters of a higher disease burden, APOE ε4 homozygosity was identified as a potential predictor of cognitive performance in this large cohort of patients with CIS and early RRMS.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology |
UniBE Contributor: |
Salmen, Anke |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2332-7812 |
Publisher: |
Wolters Kluwer Health |
Language: |
English |
Submitter: |
Chantal Kottler |
Date Deposited: |
30 Oct 2020 17:00 |
Last Modified: |
05 Dec 2022 15:41 |
Publisher DOI: |
10.1212/NXI.0000000000000728 |
PubMed ID: |
32358224 |
BORIS DOI: |
10.7892/boris.147187 |
URI: |
https://boris.unibe.ch/id/eprint/147187 |